{
    "clinical_study": {
        "@rank": "55538", 
        "brief_summary": {
            "textblock": "To compare the safety, toxicity, and tolerance of two doses of ribavirin in combination with\n      didanosine (ddI) to HIV-infected children. To determine the toxicity of ddI/ribavirin and\n      compare it to the expected toxicity of ddI monotherapy. To determine the effect of\n      concurrent ribavirin on the pharmacokinetics of ddI. To determine a dosage of ribavirin that\n      would be suitable for a Phase II/III evaluation of ddI/ribavirin.\n\n      Ribavirin, a broad spectrum antiviral agent, may enhance the antiretroviral activity of\n      didanosine ( ddI ) without a concomitant increase in toxicity. Ribavirin alters the\n      intracellular metabolism of ddI, enhancing the antiretroviral activity of the active form of\n      ddI."
        }, 
        "brief_title": "A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.", 
        "completion_date": {
            "#text": "July 1998", 
            "@type": "Actual"
        }, 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Ribavirin, a broad spectrum antiviral agent, may enhance the antiretroviral activity of\n      didanosine ( ddI ) without a concomitant increase in toxicity. Ribavirin alters the\n      intracellular metabolism of ddI, enhancing the antiretroviral activity of the active form of\n      ddI.\n\n      Patients are divided into two cohorts. Subjects will be stratified by age 3 months to < 24\n      months and >= 24 months to 12 years.  Fifty % of patients from each age group will be\n      assigned to each cohort. Cohort 1 receives ddI monotherapy for 4 weeks, followed by\n      combination ddl/ribavirin therapy for an additional 20 weeks. Cohort 2 receives combination\n      ddI/ribavirin for 24 weeks. In both cohorts, after study medications are stopped, patients\n      are treated with prescription antiretrovirals for 4 more weeks. [AS PER AMENDMENT 7/2/96:\n      Note: In each cohort of 10 subjects at least 2 of 5 children from the older half of the\n      cohort will have an ICD p24 antigen at entry.]"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Recommended:\n\n          -  PCP prophylaxis.\n\n        Allowed:\n\n          -  Acetaminophen for no more than 72 hours.\n\n          -  Immunoglobulin.\n\n          -  Corticosteroids.\n\n          -  Erythropoietin.\n\n          -  G-CSF and GM-CSF.\n\n          -  Ethionamide or isoniazid for TB if no alternative available.\n\n          -  Immunizations according to current recommendations.\n\n        Patients must have:\n\n          -  HIV infection.\n\n          -  Immunologic abnormality or clinical symptoms as detailed in the Disease Status field.\n\n          -  No active AIDS-defining opportunistic infection or malignancy, no progressive\n             encephalopathy attributable to HIV and no chronic persistent diarrhea.\n\n          -  Consent of parent or guardian.\n\n        PER AMENDMENT 7/2/96:\n\n          -  At least 2 of the 5 children in the older half of each cohort must have an ICD p24\n             antigen concentration >= 70 pg/ml at screening.\n\n        Prior Medication:\n\n        Allowed:\n\n          -  Up to 6 weeks of prior immunomodulator therapy.\n\n          -  Maternal immunomodulator or antiretroviral therapy, including during pregnancy.\n\n          -  Prior corticosteroids or intravenous immunoglobulin.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Current grade 3 or worse neuropathy/lower motor neuropathy.\n\n          -  Clinical or laboratory grade 3 or worse toxicities.\n\n          -  Active serious bacterial infection.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Chemotherapy for active malignancy.\n\n          -  Antiretrovirals other than study drugs.\n\n          -  Immunomodulators unless specifically allowed.\n\n        Patients with the following prior condition are excluded:\n\n          -  History of grade 3 or worse neuropathy/lower motor neuropathy.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Prior ddI or oral ribavirin.\n\n          -  Aerosolized ribavirin within 6 weeks prior to study entry.\n\n          -  Antiretroviral or immunomodulator therapy (other than corticosteroids or IVIG) within\n             1 week prior to blood draws for study entry.\n\n        Ongoing drug or alcohol abuse."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "3 Months"
        }, 
        "enrollment": "20", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000833", 
            "org_study_id": "ACTG 274", 
            "secondary_id": "11250"
        }, 
        "intervention": [
            {
                "intervention_name": "Ribavirin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Didanosine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Didanosine", 
                "Ribavirin"
            ]
        }, 
        "keyword": [
            "Ribavirin", 
            "Didanosine", 
            "Drug Therapy, Combination", 
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex", 
            "Antiviral Agents"
        ], 
        "lastchanged_date": "May 1, 2012", 
        "link": [
            {
                "description": "Click here for more information about Didanosine", 
                "url": "http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=16"
            }, 
            {
                "description": "Click here for more information about Ribavirin", 
                "url": "http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=28"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20060"
                    }, 
                    "name": "Howard Univ Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "200102916"
                    }, 
                    "name": "Children's Hosp of Washington DC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32209"
                    }, 
                    "name": "Univ of Florida Health Science Ctr / Pediatrics"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "701122699"
                    }, 
                    "name": "Tulane Univ / Charity Hosp of New Orleans"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "021155724"
                    }, 
                    "name": "Children's Hosp of Boston"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "071032714"
                    }, 
                    "name": "Univ of Medicine & Dentistry of New Jersey / Univ Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "071072198"
                    }, 
                    "name": "Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10457"
                    }, 
                    "name": "Bronx Lebanon Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Hyde Park", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11040"
                    }, 
                    "name": "Schneider Children's Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Columbia Presbyterian Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10037"
                    }, 
                    "name": "Harlem Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Incarnation Children's Ctr / Columbia Presbyterian Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Research Triangle Park", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27709"
                    }, 
                    "name": "Glaxo Wellcome Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Texas Children's Hosp / Baylor Univ"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Juan", 
                        "country": "Puerto Rico", 
                        "zip": "009365067"
                    }, 
                    "name": "Univ of Puerto Rico / Univ Children's Hosp AIDS"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Puerto Rico"
            ]
        }, 
        "official_title": "A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.", 
        "overall_official": [
            {
                "last_name": "Van Dyke R", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "McSherry G", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "reference": {
            "citation": "McKinney RE Jr. Ongoing and future trials of antiretroviral therapy in the pediatric AIDS clinical trials group (PACTG). Conf Retroviruses Opportunistic Infect. 1996 Jan 28-Feb 1;3rd:173"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000833"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2012"
    }, 
    "geocoordinates": {
        "Bronx Lebanon Hosp Ctr": "40.85 -73.867", 
        "Children's Hosp of Boston": "42.358 -71.06", 
        "Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl": "40.736 -74.172", 
        "Children's Hosp of Washington DC": "38.895 -77.036", 
        "Columbia Presbyterian Med Ctr": "40.714 -74.006", 
        "Glaxo Wellcome Inc": "35.902 -78.867", 
        "Harlem Hosp Ctr": "40.714 -74.006", 
        "Howard Univ Hosp": "38.895 -77.036", 
        "Incarnation Children's Ctr / Columbia Presbyterian Med Ctr": "40.714 -74.006", 
        "Schneider Children's Hosp": "40.735 -73.688", 
        "Texas Children's Hosp / Baylor Univ": "29.76 -95.369", 
        "Tulane Univ / Charity Hosp of New Orleans": "29.951 -90.072", 
        "Univ of Florida Health Science Ctr / Pediatrics": "30.332 -81.656", 
        "Univ of Medicine & Dentistry of New Jersey / Univ Hosp": "40.736 -74.172", 
        "Univ of Puerto Rico / Univ Children's Hosp AIDS": "18.466 -66.106"
    }
}